{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T12:10:50Z","timestamp":1779106250567,"version":"3.51.4"},"reference-count":25,"publisher":"SAGE Publications","issue":"11","license":[{"start":{"date-parts":[[2009,10,5]],"date-time":"2009-10-05T00:00:00Z","timestamp":1254700800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Human Gene Therapy"],"published-print":{"date-parts":[[2009,11]]},"abstract":"<jats:p>\n                    The use of nonionic polymeric micelles orally to protect and deliver plasmid DNA\n                    <jats:italic toggle=\"yes\">in vivo<\/jats:italic>\n                    was investigated. Parathyroid hormone (PTH)(1\u201334) gene (179\u2009bp) was inserted into a human cytomegalovirus promoter (PCMV) and\n                    <jats:italic toggle=\"yes\">E. coli<\/jats:italic>\n                    competent cells were used to amplify the cDNA. Polymeric micelle formations (100\u2009\u03bcl) formed from PCMV-PTH(1\u201334) cDNA (7.2\u2009\u03bcg\/\u03bcl) and 6% (w\/v) polyethylene oxide-polypropylene oxide-polyethylene oxide (PEO-PPO-PEO) was administered at 8-hr intervals for 48\u2009hr and then at 8-hr intervals for 24\u2009hr weekly for 3 weeks. Parathyroidectomized rats receiving 150\u2009\u03bcl of EDTA (10\u2009m\n                    <jats:italic toggle=\"yes\">M<\/jats:italic>\n                    ) before each dose of formation served as the study group; rats receiving drinking water, EDTA (10\u2009m\n                    <jats:italic toggle=\"yes\">M<\/jats:italic>\n                    ), PCMV-PTH(1\u201334) cDNA and PCMV-PTH(1\u201334) cDNA plus EDTA at the same amount and time intervals served as the control groups. Serum levels of calcium and PTH(1\u201334) were measured weekly for 4 weeks. Immunohistochemical stain for PTH(1\u201334), reverse transcriptase polymerase chain reaction for PTH(1\u201334) mRNA and the relative density of PTH(1\u201334) mRNA were performed at 2 and 4 weeks after oral gene therapy in different organs. One third to three of five rats in the control groups died after parathyroidectomy. Serum levels of calcium and PTH(1\u201334) were higher in the study than in the control groups. In the study group, positive stain of PTH(1\u201334) and PTH(1\u201334) mRNA could be found in those organs. Relative densities of PTH(1\u201334) mRNA were higher in the study than in the drinking water group in different organs. Oral gene therapy can maintain calcium and PTH(1\u201334) levels in parathyroidectomized rats.\n                  <\/jats:p>","DOI":"10.1089\/hum.2009.015","type":"journal-article","created":{"date-parts":[[2009,7,20]],"date-time":"2009-07-20T09:54:30Z","timestamp":1248083670000},"page":"1344-1350","source":"Crossref","is-referenced-by-count":9,"title":["Oral Gene Therapy for Hypoparathyroidism: A Rat Model"],"prefix":"10.1177","volume":"20","author":[{"given":"Fong-Fu","family":"Chou","sequence":"first","affiliation":[{"name":"Chang Gung University College of Medicine","place":["Taiwan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shun-Chen","family":"Huang","sequence":"additional","affiliation":[{"name":"Chang Gung University College of Medicine","place":["Taiwan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shwu-Fen","family":"Chang","sequence":"additional","affiliation":[{"name":"Taipei Medical University Taipei 110","place":["Taiwan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiahorng","family":"Liaw","sequence":"additional","affiliation":[{"name":"Taipei Medical University Taipei 110","place":["Taiwan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pei-Hua","family":"Hung","sequence":"additional","affiliation":[{"name":"Chang Gung University College of Medicine","place":["Taiwan"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2009,10,5]]},"reference":[{"key":"e_1_3_3_2_1","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.7.9.1453"},{"key":"e_1_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng1093-135"},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.1089\/10430340460745801"},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-3659(01)00299-1"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/jbm.a.31704"},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-3659(02)00009-3"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/0169-409X(95)00031-2"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1011991617857"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/0168-3659(94)90118-X"},{"key":"e_1_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-3659(00)00268-6"},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.gt.3301485"},{"key":"e_1_3_3_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2003.11.032"},{"key":"e_1_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/jgm.1304"},{"key":"e_1_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp0803050"},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/0169-409X(95)00025-3"},{"key":"e_1_3_3_17_1","first-page":"313","article-title":"Milk-alkali syndrome induced by 1, 25(OH) 2D in a patient with hypoparathyroidism","volume":"88","author":"Tal A.","year":"1996","unstructured":"Tal A., , Powers K. 1996. Milk-alkali syndrome induced by 1, 25(OH) 2D in a patient with hypoparathyroidism. J. Natl. Med. Assoc., 88:313\u2013314.","journal-title":"J. Natl. Med. Assoc."},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.04-1078"},{"key":"e_1_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/jgm.1093"},{"key":"e_1_3_3_20_1","first-page":"260","article-title":"pcDPG parathyroid hormone gene therapy of hypoparathyroidism","volume":"86","author":"Wen J.M.","year":"2006","unstructured":"Wen J.M., , Zhong Y.H., , Sun Y., , Hung Z., , Zhang L.W., , Wu QL., , Zeng D.C. 2006. pcDPG parathyroid hormone gene therapy of hypoparathyroidism. Zhonghua Yi Xue Za Zhi, 86:260\u2013265.","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"e_1_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1996.03540080053029"},{"key":"e_1_3_3_22_1","first-page":"4241","article-title":"Long-term treatment of hypoparathyroidism: A randomized control study comparing parathyroid hormone (1\u201334) versus calcitriol and calcium","volume":"880","author":"Winer K.K.","year":"2003","unstructured":"Winer K.K., , Ko C.W., , Reynolds J.C. 2003. Long-term treatment of hypoparathyroidism: A randomized control study comparing parathyroid hormone (1\u201334) versus calcitriol and calcium. J. Clin. Endocrinol. Metab., 880:4241\u20134220.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"e_1_3_3_23_1","first-page":"213","article-title":"Block copolymers as drug carriers","volume":"9","author":"Yokoyama M.","year":"1992","unstructured":"Yokoyama M. 1992. Block copolymers as drug carriers. Crit. Rev. Ther. Drug Carrier Syst., 9:213\u2013248.","journal-title":"Crit. Rev. Ther. Drug Carrier Syst."},{"key":"e_1_3_3_24_1","doi-asserted-by":"publisher","DOI":"10.1002\/jbm.a.31950"},{"key":"e_1_3_3_25_1","first-page":"204","article-title":"Optimising gene therapy of hypoparathyroidism with hematopoietic stem cells","volume":"118","author":"Zhou Y.","year":"2005","unstructured":"Zhou Y., , Lu B., , Xu P., , Song C.F. 2005. Optimising gene therapy of hypoparathyroidism with hematopoietic stem cells. Chin. Med. J., 118:204\u2013209.","journal-title":"Chin. Med. J."},{"key":"e_1_3_3_26_1","first-page":"837","article-title":"pcKM-mPTH recombinant plasmid therapy for hypoparathyroidism by polycationic liposome mediated transfection","volume":"86","author":"Zhu Y.F.","year":"2006","unstructured":"Zhu Y.F., , Ye J.L., , Wang S.M. 2006. pcKM-mPTH recombinant plasmid therapy for hypoparathyroidism by polycationic liposome mediated transfection. Zhonghua Yi Xue Za Zhi, 86:837\u2013840.","journal-title":"Zhonghua Yi Xue Za Zhi"}],"container-title":["Human Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/hum.2009.015","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/hum.2009.015","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/hum.2009.015","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T11:16:55Z","timestamp":1779103015000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1089\/hum.2009.015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10,5]]},"references-count":25,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["10.1089\/hum.2009.015"],"URL":"https:\/\/doi.org\/10.1089\/hum.2009.015","relation":{},"ISSN":["1043-0342","1557-7422"],"issn-type":[{"value":"1043-0342","type":"print"},{"value":"1557-7422","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,10,5]]}}}